Home › Gastrointestinal Cancers
Gastrointestinal Cancers clinical trials recruiting in the U.S.
72 studies for Gastrointestinal Cancers are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX21 studies
- Boston, MA15 studies
- New York City, NY12 studies
- Nashville, TN10 studies
- Los Angeles, CA9 studies
- Dallas, TX8 studies
- Durham, NC8 studies
- Baltimore, MD8 studies
- Arlington, VA8 studies
- Cincinnati, OH8 studies
- Aurora, CO7 studies
- Seattle, WA7 studies
- San Antonio, TX7 studies
- Philadelphia, PA6 studies
- Baldwin Park, CA6 studies
- Chicago, IL6 studies
- Washington, DC6 studies
- St. Louis, MO6 studies
- Grand Rapids, MI6 studies
- Queens, NY5 studies
- San Francisco, CA5 studies
- Tampa, FL5 studies
- Atlanta, GA5 studies
- Indianapolis, IN5 studies
- Phoenix, AZ4 studies
- Omaha, NE4 studies
- Rochester, MN4 studies
- Ann Arbor, MI4 studies
- San Diego, CA4 studies
- Columbus, OH4 studies
- New Haven, CT4 studies
- Salt Lake City, UT4 studies
- Pittsburgh, PA4 studies
- Detroit, MI4 studies
- Madison, WI4 studies
- Mountain View, CA4 studies
- Sacramento, CA4 studies
- Oklahoma City, OK4 studies
- Sarasota, FL4 studies
- Jacksonville, FL3 studies
By state
- Arizona8 studies
- Arkansas3 studies
- California27 studies
- Colorado10 studies
- Connecticut5 studies
- Florida16 studies
- Georgia7 studies
- Illinois9 studies
- Indiana6 studies
- Iowa3 studies
- Kansas5 studies
- Louisiana3 studies
- Maine3 studies
- Maryland14 studies
- Massachusetts15 studies
- Michigan13 studies
- Minnesota7 studies
- Missouri6 studies
- Nebraska5 studies
- New Jersey3 studies
- New Mexico3 studies
- New York14 studies
- North Carolina11 studies
- Ohio15 studies
- Oklahoma4 studies
- Oregon3 studies
- Pennsylvania9 studies
- South Carolina3 studies
- South Dakota3 studies
- Tennessee13 studies
- Texas26 studies
- Utah4 studies
- Virginia10 studies
- Washington8 studies
- Wisconsin8 studies
Recently updated studies
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07529808Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07218926DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06855524A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06663319Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05274048GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
RecruitingEarly phase 1
Ages 18 to 99 · All sexes · Updated Sep 18, 2026 · NCT07627191SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Recruiting
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05375643Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06633224EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06263088Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT01313442Resilience and Equity in Aging, Cancer, and Health (REACH)
Recruiting
Ages 65 and older · All sexes · Updated Sep 10, 2026 · NCT04674267Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT04899908Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07539311Personalized Health Self-Management Training for Colorectal Cancer Survivors
Recruiting
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05984589The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT04700527A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06760819Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07283939A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05837767Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT06596694A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07544589Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06582017From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.